| Literature DB >> 34611205 |
Johan Lyngklip Hermansen1,2, Gabriela Pettey3, Heidi Tofte Sørensen4, Samantha Nel5, Nqoba Tsabedze5, Arne Hørlyck6, Palesa Motshabi Chakane3, Henrik Gammelager7,8, Peter Juhl-Olsen4,7.
Abstract
Acute kidney injury (AKI) is a frequent and severe complication in cardiac surgery. Normal renal function is dependent on adequate renal perfusion, which may be altered in the perioperative period. Renal perfusion can be assessed with Doppler measurement. We aimed to determine the association between Doppler measurements of renal perfusion and the development of AKI. This was a prospective, observational study of 100 patients with ≥ one risk factor for postoperative AKI undergoing open-heart surgery. Doppler ultrasound examinations were performed before surgery and on the first and fourth postoperative day. AKI was defined according to the KDIGO criteria and subdivided into mild (KDIGO stage 1) and severe AKI (KDIGO stage 2 + 3). Thirty-three patients developed AKI, 25 developed mild and eight developed severe AKI. Abnormal renal venous flow pattern on the first postoperative day was significantly associated with the development of severe AKI (OR 8.54 (95% CI 1.01; 72.2), P = 0.046), as were portal pulsatility fraction (OR 1.07 (95% CI 1.02; 1.13), P = 0.005). Point-of-care Doppler ultrasound measurements of renal perfusion are associated with the development of AKI after cardiac surgery. Renal and portal Doppler ultrasonography can be used to identify patients at high risk or very low risk of AKI after cardiac surgery.Entities:
Mesh:
Year: 2021 PMID: 34611205 PMCID: PMC8492663 DOI: 10.1038/s41598-021-99141-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flowchart of patients and ultrasound examinations in the study, including inclusion and exclusion criteria.
Baseline patient characteristics. Median and interquartile range (IQR) or number (n) and percent.
| No AKI (n = 67) | Mild AKI (n = 25) | Severe AKI (n = 8) | P-value | |
|---|---|---|---|---|
| Age, years | 72 (64; 75) | 73 (70; 77) | 62 (61; 70) | 0.024* |
| Male, n | 53 (79%) | 21 (84%) | 5 (63%) | 0.66 |
| Height (m) | 1.73 (1.68; 1.79) | 1.72 (1.65; 1.76) | 1.72 (1.63; 1.78) | 0.29 |
| Weight (kg) | 80.3 (74.0; 93.1) | 80.7 (72.8; 89.1) | 77.4 (70.7; 86.5) | 0.57 |
| BMI (kg/m2) | 27.5 (24.9; 30.8) | 28.5 (25.3; 30.3) | 27.5 (23.7; 30.2) | 0.93 |
| CABG, n | 33 (49%) | 12 (48%) | 1 (13%) | 0.06 |
| Aortic valve, n | 6 (9%) | 3 (12%) | 1 (13%) | |
| Mitral valve, n | 6 (9%) | 4 (16%) | 2 (25%) | |
| Two procedures, n | 17 (25%) | 4 (16%) | 3 (38%) | |
| PTEA, n | 5 (7%) | 2 (8%) | 0 (0%) | |
| Thoracic aortic surgery, n | 0 (0%) | 0 (0%) | 1 (13%) | |
| Active endocarditis, n | 0 (0%) | 2 (8%) | 0 (0%) | 0.048* |
| Re-do surgery, n | 5 (7%) | 4 (16%) | 5 (63%) | < 0.001* |
| EuroSCORE II | 1.58 (1.13; 2.00) | 2.54 (1.48; 3.90) | 3.60 (2.90; 4.82) | < 0.001* |
| Hypertension, n | 47 (70%) | 17 (68%) | 7 (88%) | 0.55 |
| Diabetes mellitus | 0.50 | |||
| No, n | 54 (81%) | 18 (72%) | 6 (75%) | |
| NIDDM, n | 7 (10%) | 4 (16%) | 0 (0%) | |
| IDDM, n | 6 (9%) | 3 (12%) | 2 (25%) | |
| Smoking | 0.96 | |||
| Present, n | 10 (15%) | 4 (16%) | 1 (13%) | |
| Previous, n | 17 (25%) | 7 (28%) | 3 (38%) | |
| Never, n | 40 (60%) | 14 (56%) | 4 (50%) | |
| Hypercholesterolemia, n | 39 (58%) | 15 (60%) | 3 (38%) | 0.50 |
| Ischemic heart disease, n | 36 (54%) | 13 (52%) | 3 (38%) | 0.69 |
| Myocardial infarction < 90 days, n | 15 (22%) | 5 (20%) | 0 (0%) | 0.33 |
| Known peripheral artery disease, n | 4 (6%) | 4 (16%) | 0 (0%) | 0.20 |
| eGFR < 60 ml/min/1.73 m2, n | 13 (19%) | 14 (56%) | 0 (0%) | < 0.001* |
| NYHA 3–4, n | 4 (6%) | 3 (12%) | 2 (25%) | 0.17 |
| Left ventricular ejection fraction | 0.43 | |||
| > 50%, n | 47 (70%) | 16 (64%) | 4 (50%) | |
| 35–50%, n | 15 (22%) | 6 (24%) | 4 (50%) | |
| < 35%, n | 5 (7%) | 3 (12%) | 0 (0%) | |
| Pulmonary hypertension, n | 9 (13%) | 7 (28%) | 1 (13%) | 0.24 |
| COPD, n | 4 (6%) | 6 (24%) | 2 (25%) | 0.031* |
| BMI > 35, n | 7 (10%) | 4 (16%) | 0 (0%) | 0.44 |
P-values refer to difference between any of two of groups no AKI, mild AKI and severe AKI. No AKI, mild AKI and severe AKI refer to patients who did not develop AKI, developed mild AKI (KDIGO grade 1) or developed severe AKI (KDIGO grades 2 + 3) within the first 4 postoperative days. * indicates statistically significant difference (P < 0.05).
AKI acute kidney injury, BMI body mass index, CABG coronary artery bypass grafting, COPD chronic obstructive pulmonary disease, eGFR estimated glomerular filtration rate, IDDM insulin dependent diabetes mellitus, KDIGO kidney disease improving global outcomes, NIDDM non-insulin dependent diabetes mellitus, NYHA New York Heart Association, PTEA pulmonary thromboendarterectomy.
Figure 2Distribution of patients within each of the venous ultrasound measurements in per cent according to different time points. Patients were divided according to the degree of AKI. Day − 1, + 1 and + 4 refer to the day before surgery, the first postoperative day and the fourth postoperative day. No AKI, mild AKI and severe AKI refer to patients who did not develop AKI, developed mild AKI (KDIGO grade 1) or developed severe AKI (KDIGO grades 2 + 3) within the first four postoperative days. *indicates statistically significant difference (P < 0.05) when comparing patients with no AKI and patients with either mild or severe AKI. See Table s1, supplementary material for exact values. AKI acute kidney injury, KDIGO kidney disease improving global outcomes.
Univariate and multivariate logistic regression models for the odds ratio (OR) of developing AKI after cardiac surgery according to studied variables on the first postoperative day.
| Ultrasound indices 1st postoperative day | Univariate analyses | Multivariate analyses | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P-value | OR | 95% CI | P-value | |
| Normal | 1.0 (Ref) | 1.0 (Ref) | ||||
| Abnormal | 2.83 | (1.18; 6.80) | 0.020* | 1.69 | (0.60; 4.80) | 0.32 |
| Low (0–0.30) | 1.0 (Ref) | 1.0 (Ref) | ||||
| High (0.31–1.00) | 3.19 | (1.31; 7.78) | 0.011* | 1.70 | (0.58; 4.94) | 0.33 |
| Resistive index | 1.21 | (1.10; 1.34) | < 0.001* | 1.23 | (1.09; 1.40) | 0.001* |
| Portal pulsatility fraction | 1.02 | (1.00; 1.05) | 0.08 | 1.01 | (0.98; 1.03) | 0.55 |
Multivariate logistic regression adjusted for cardiopulmonary bypass (CPB) time and EuroSCORE II. OR, 95% CI (confidence interval) and P-value for developing any degree of AKI after cardiac surgery with no AKI as reference group. All values except EuroSCORE II refer to the first postoperative day. Renal venous flow pattern and renal venous stasis index (RVSI) are treated as categorical variables. Other variables are treated as continuous variables. Higher OR depicts higher risk of AKI. * Indicates statistically significant difference (P < 0.05).
AKI acute kidney injury, CPB cardiopulmonary bypass.
Univariate logistic regression.
| Time | Mild AKI (n = 25) | Severe AKI (n = 8) | |||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | P-value | OR | 95% CI | P-value | ||
| Compared to normal renal venous flow pattern | − 1 | 2.06 | (0.58; 7.32) | 0.26 | 3.5 | (0.73; 16.6) | 0.06 |
| + 1 | 2.07 | (0.80; 5.35) | 0.13 | 8.54 | (1.01; 72.2) | 0.046* | |
| + 4 | 1.96 | (0.67; 5.70) | 0.22 | 2.41 | (0.50; 11.6) | 0.27 | |
| Compared to RVSI (0–0.30) | − 1 | 2.06 | (0.50; 8.51) | 0.32 | 4.53 | (0.92; 22.3) | 0.06 |
| + 1 | 1.91 | (0.70; 5;19) | 0.20 | 18.48 | (2.16; 158) | 0.008* | |
| + 4 | 1.78 | (0.59; 5.40) | 0.31 | 2.10 | (0.43; 10.2) | 0.36 | |
| Per 0.01 increase | − 1 | 0.99 | (0.95; 1.03) | 0.60 | 1.02 | (0.96; 1.09) | 0.50 |
| + 1 | 1.00 | (0.97; 1.03) | 0.88 | 1.07 | (1.02; 1.13) | 0.005* | |
| + 4 | 1.02 | (0.98; 1.06) | 0.38 | 1.06 | (1.01; 1.12) | 0.021* | |
| Per 0.01 increase | − 1 | 1.02 | (0.96; 1.08) | 0.49 | 1.02 | (0.71; 1.11) | 0.71 |
| + 1 | 1.19 | (1.08; 1.32) | 0.001* | 1.17 | (1.02; 1.35) | 0.023* | |
| + 4 | 1.04 | (0.95; 1.12) | 0.41 | 1.02 | (0.90; 1.15) | 0.74 | |
| Lower MAP increases OR | + 1 | 1.05 | (0.90; 1.01) | 0.09 | 1.15 | (1.02; 1.29) | 0.022* |
| Higher CVP increases OR | + 1 | 1.00 | (0.87; 1.16) | 0.93 | 1.91 | (1.23; 2.96) | 0.004* |
| Lower SPP increases OR | + 1 | 1.04 | (0.99; 1.10) | 0.10 | 1.24 | (1.07; 1.43) | 0.003* |
| Lower PP increases OR | + 1 | 1.04 | (1.01; 1.08) | 0.017 * | 1.05 | (0.99; 1.10) | 0.10 |
| Lower PPI increases OR | + 1 | 1.05 | (0.99; 1.10) | 0.10 | 1.02 | (0.94; 1.11) | 0.58 |
Odds ratio (OR), 95% CI (confidence interval) and P-value for developing mild AKI and severe AKI, respectively after cardiac surgery with no AKI as reference group.
The numbers − 1, + 1 and + 4 refer to the time of the ultrasound examination at the day before surgery, the first postoperative day and the fourth postoperative day. Abnormal venous flow pattern and renal venous stasis index (RVSI) are treated as dichotomous variables and resistive index portal pulsatility fraction and hemodynamic values are treated as continuous variables. Higher OR depicts higher risk of mild or severe AKI. No AKI, mild AKI and severe AKI refers to patients who did not develop AKI, developed mild AKI (KDIGO grade 1) or developed severe AKI (KDIGO2 + 3) within the first four postoperative days. * Indicates statistically significant difference (P < 0.05).
Receiver operating characteristics (ROC) of the studied ultrasound indices on the first postoperative day in relation to correctly classifying patients with any degree of AKI (KDIGO stage 1 + 2 + 3) (upper panel) and severe AKI (KDIGO stage 2 + 3) in the lower panel.
| Ultrasound parameter and threshold—1st postoperative day | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | LR+ | LR− | AUC (95% CI) |
|---|---|---|---|---|---|---|---|
| Abnormal renal venous flow pattern | 65.6 (46.8; 81.4) | 59.7 (47.0; 71.5) | 43.8 (29.5; 58.8) | 78.4 (64.7; 88.7) | 1.63 | 0.576 | 0.63 (0.52; 0.73) |
| De novo abnormal renal venous flow pattern | 58.3 (36.6; 77.9) | 61.7 (48.2; 73.9) | 37.8 (22.5; 55.2) | 78.7 (64.3; 89.3) | 1.52 | 0.676 | 0.60 (0.48; 0.72) |
| RVSI ≥ 0.31 | 50.0 (31.9; 68.1) | 76.1 (64.1; 85.7) | 50.0 (31.9; 68.1) | 76.1 (64.1; 85.7) | 2.09 | 0.657 | 0.63 (0.53; 0.73) |
| RI ≥ 0.73 | 87.5 (71.0; 96.5) | 58.2 (45.5; 70.2) | 50.0 (36.3; 63.7) | 90.7 (77.9; 97.4) | 2.09 | 0.215 | 0.73 (0.65; 0.81) |
| Portal pulsatility fraction ≥ 0.43 | 50.0 (31.9; 68.1) | 71.6 (59.3; 82.0) | 45.7 (28.8; 63.4) | 75.0 (62.6; 85.0) | 1.76 | 0.698 | 0.61 (0.51; 0.71) |
| RI < 0.73 and RVSI < 0.31 | 90.6 (75.0; 98.0) | 46.3 (34.0; 58.9) | 44.6 (32.2; 57.5) | 91.2 (76.3; 98.1) | 1.69 | 0.203 | 0.68 (0.60; 0.76) |
| RI ≥ 0.73 and RVSI ≥ 0.31 | 46.9 (29.1; 65.3) | 88.1 (77.8; 94.7) | 65.2 (42.7; 83.6) | 77.6 (66.6; 86.4) | 3.93 | 0.603 | 0.68 (0.56; 0.77) |
| Abnormal renal venous flow pattern | 87.5 (47.3; 99.7) | 54.9 (44.2; 65.4) | 14.6 (6.1; 27.8) | 98.0 (89.6; 100) | 1.94 | 0.228 | 0.71 (0.58; 0.85) |
| De novo abnormal renal venous flow pattern | 100 (47.8; 100) | 59.5 (47.9; 70.4) | 13.5 (4.5; 28.8) | 100 (92.5; 100) | 2.47 | 0 | 0.80 (0.74; 0.85) |
| RVSI ≥ 0.31 | 87.5 (47.3; 99.7) | 72.5 (62.2; 81.4) | 21.9 (9.3; 40.0) | 98.5 (92.0; 100) | 3.19 | 0.172 | 0.80 (0.67; 0.93) |
| RI ≥ 0.73 | 87.5 (47.3; 99.7) | 46.2 (35.6; 56.9) | 12.5 (5.2; 24.1) | 97.7 (87.7; 99.9) | 1.63 | 0.271 | 0.67 (0.54; 0.80) |
| Portal pulsatility fraction ≥ 0.43 | 87.5 (47.3; 99.7) | 69.2 (58.7; 91.5) | 20.0 (8.4; 36.9) | 98.4 (91.6; 100) | 2.84 | 0.181 | 0.78 (0.65; 0.92) |
| RI < 0.73 and RVSI < 0.31 | 100 (63.1; 100) | 37.4 (27.4; 48.1) | 12.3 (5.5; 22.8) | 100 (89.7; 100) | 1.57 | 0 | 0.69 (0.64; 0.74) |
| RI ≥ 0.73 and RVSI ≥ 0.31 | 75.0 (34.9; 96.8) | 81.3 (71.8; 88.7) | 26.1 (10.2; 48.4) | 97.4 (90.8; 99.7) | 4.01 | 0.307 | 0.78 (0.62; 0.95) |
De novo abnormal renal venous flow pattern was defined as normal pattern preoperatively and abnormal renal venous flow pattern on the first postoperative day.
AKI acute kidney injury, AUC area under the curve, CI confidence interval, KDIGO Kidney Disease Improving Global Outcomes, LR + positive likelihood ratio, LR − negative likelihood ratio, NPV negative predictive value, PPV positive predictive value, RI resistive index, RVSI renal venous stasis index.